Latest filing published 24 Apr 2023 for Mind Medicine (MindMed) Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Miri Halperin Wernli: trading record in brief
This profile gathers the share dealings of Miri Halperin Wernli in Definium Therapeutics, Inc., where the filings describe the role as chief executive. The record holds 3 filings, for trades running from 24 March 2022 to 14 March 2023.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 24 April 2023, reports a share grant in Definium Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Miri Halperin Wernli
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 100,000 shares0Common SharesSEC:0001209191-23-025475:0
- 100,000 shares0Common SharesSEC:0001209191-23-019893:0
- 600,000 shares0Subordinate Voting SharesSEC:0001209191-22-021391:0
3 of 3 declarations
